SHANGHAI, Oct. 14, 2025 /PRNewswire/ -- Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines ...

A second child, less than a month old, caught a cold from their older sibling who had just returned from kindergarten. The ...

Jo Goldsmith is advising pregnant women to take up the vaccine [BBC] A woman whose newborn daughter became ill after catching a potentially serious respiratory illness is urging other pregnant women ...

-- Positive Phase 2 (Australia) results strengthen potential best-in-class profile of RSV+hMPV±PIV3 combination vaccines, with the potential differentiated ability to re-vaccinate individuals ...

Merck & Co. (MRK), known as MSD outside the United States and Canada, on Thursday reported positive second-season results from the Phase 3 SMART trial evaluating ENFLONSIA (clesrovimab) in infants and ...

(WYTV)- When winter hits, runny noses and coughs come with the season. But doctors say one virus in particular can cause serious problems for young children–RSV. “RSV, also known as respiratory ...

Using a latent class analysis model, researchers demonstrated that standard test positivity rates overestimate the true prevalence of RSV due to testing inaccuracies. The hospitalization rate for ...

CAMBRIDGE, MA, June 28, 2024 (Newswire.com) - Moderna, Inc. (Nasdaq:MRNA) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a ...

Goldman Sachs said Monday that GSK (NYSE:GSK) is set for a 'positive surprise' this week as a CDC Advisory Committee is scheduled to discuss whether to broaden the recommendation for Arexvy, the ...